Clinical trial
Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release…
NCT00481689 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00481689 |
|---|---|
| Title | Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens |
| Official title | Prospective, Open-Label, Noncomparative, Multicenter Study to Evaluate the Efficacy and Safety of Ciprofloxacin Extended Release (Cipro XR) 1000 mg Tablets Given Once Daily for 7 to 14 Days in the Treatment of Patients 18 Years or Older With Complicated Urinary Tract Infections Caused by Pseudomonas… |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Urinary Tract Infections |
| Intervention type | Drug |
| Interventions | Cipro XR (Ciprofloxacin, BAYQ3939) |
| Enrollment | 500 |
| Start date | May 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Jun 4, 2007 |
| Last update posted | Jun 26, 2009 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: